DUBLIN, June 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/l9vkgt/pediatric) has announced the addition of the "2014 Report on the International Pediatric Interventional Cardiology Market - Forecasts to 2018" report to their offering.
The global pediatric interventional cardiology market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well.
The transcatheter heart valve market is the fastest growing segment in the pediatric interventional cardiology market. In 2010, the first pediatric specific transcatheter pulmonary heart valve was launched in the U.S. market. Companies in this market are engaged in the development of new and improved transcatheter heart valves, which is a major reason for its high growth. In addition, this market is witnessing a number of venture capitalist investments, which is aiding in the development and launch of new products in this market.
In the coming years, the APAC and RoW regions are expected to grow at high CAGRs. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets in the pediatric interventional cardiology market. Both these regions offer a high growth potential as compared to mature markets such as Europe. Growth in these markets is spurred by the growing incidence of congenital heart disease (CHD). According to the American College of Cardiology Foundation, in 2010, the prevalence of CHD in Asia was 8.9 to 9.7 per 1,000 live births, whereas in Africa this figure was 1.1 to 3.5 per 1,000 live births.
The APAC region is witnessing a number of collaborations between local players and foreign companies for the development of new products. Also, the APAC region is hosting a number of conferences and workshops for discussing new and advanced techniques that are present in the market. These conferences and workshops will help in stimulating innovation in the field of pediatric interventional cardiology, thus aiding the market to grow further.
The global pediatric interventional cardiology market is highly competitive and all the existing players in this market are engaged in developing new and advanced products, to maintain their market share. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures are the factors that are likely to hinder the growth of this market. At present, difficulties encountered in clinical trials of pediatric medical devices such as patient recruitment and high cost are the major challenges faced by market players.
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Pediatric Interventional Cardiology Procedures
6 Pediatric Interventional Cardiology Devices Market
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
- Abbott Vascular
- Boston Scientific Corporation
- Cordis Corporation
- Edwards Lifesciences
- Ge Healthcare
- Gore Medical
- Medtronic, Inc.
- Numed, Inc.
- Siemens Healthcare
- St. Jude Medical
- Toshiba Corporation
For more information visit http://www.researchandmarkets.com/research/l9vkgt/pediatric
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets